- Home
- EXAS
EXAS
Exact Sciences Corporation
as 04-17-2025 4:00pm EST
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | MADISON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $68.95 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 20 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $39.97 - $72.83 | Next Earning Date: | 05-01-2025 |
| Revenue: | $2,758,867,000 | Revenue Growth: | 10.37% |
| Revenue Growth (this year): | 12.98% | Revenue Growth (next year): | 12.96% |
Latest Exact Sciences Corporation News
EXAS Breaking Stock News: Dive into EXAS Ticker-Specific Updates for Smart Investing
StockStory
3 days ago
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Zacks
4 days ago
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
Business Wire
4 days ago
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
StockStory
4 days ago
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
StockStory
7 days ago
2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution
MT Newswires
8 days ago
Mizuho Initiates Exact Sciences at Outperform With $60 Price Target
StockStory
11 days ago
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
Business Wire
17 days ago
Exact Sciences Schedules First Quarter 2025 Earnings Call
Compare EXAS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EXAS Exact Sciences Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.